- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03645772
Plyometric Exercise to Improve Rapid Force Production in Older Men
Plyometric Exercise to Improve Rapid Force Production in Older Men: a Pilot Intervention
Rapid force production declines as a consequence of ageing. Given the functional relevance of rapid force production, exercise interventions in older adults should aim at improving the capacity to produce force rapidly. To improve this capacity, exercises should be performed with the intention to develop high speeds, as supported by previous work.
Human locomotion fundamentally consists of multi-joint movements and rapidly coupled eccentric-concentric muscle actions, known as stretch-shortening cycle (SSC) activities or plyometrics. Plyometrics might therefore be used to optimize power production. However, there is limited research on the feasibility of plyometrics in older adults and its potential effects on rapid force production and functional capacity. This study will test the feasibility of a 12-week plyometric exercise intervention in older men and compare its effects on rapid force production to a traditional resistance exercise or walking intervention.
Study Overview
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Leuven, Belgium, 3001
- Department of Movement Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
-
Exclusion Criteria:
- No systematic engagement in (resistance) exercise in the 12-months prior to participation
- Cardiovascular disease
- Neurological disorders
- Cognitive malfunctioning
- Severe knee or hip problems
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Plyometric exercise
12-week progressive exercise program, consisting of plyometric exercises such as countermovement jump, forward and sideways step-up.
|
12-week progressive training intervention
|
|
ACTIVE_COMPARATOR: Resistance exercise
12-week resistance exercise program for the leg muscles (2-4 sets of 8-15 repetitions at 8-15RM, leg press, leg extension, calve extension).
|
12-week progressive training intervention
|
|
ACTIVE_COMPARATOR: Walking
12-week progressive walking program.
|
12-week progressive training intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rapid force production
Time Frame: Change from baseline in rapid force production at 12 weeks
|
Subjects perform a test protocol on a sledge apparatus, consisting of explosive isometric voluntary contractions for the leg-extensor muscles of the right leg.
The inclination of the sledge is 20° to horizontal.
The seat of the sledge is inclined backwards (130°).
The knee joint angle is set at 90° and the hip angle at 70°.
The point of force application is aligned with the head of the fifth metatarsal.
Subjects are instructed to kick as fast and as hard as possible and maintain their maximum force for approximately 3s.
The rate of force development (N/s) is defined as the linear slope of the force-time curve and is measured from the onset of movement till 100 ms.
|
Change from baseline in rapid force production at 12 weeks
|
|
Jumping height in squat jump
Time Frame: Change from baseline in jumping height at 12 weeks
|
Subjects perform a test protocol on a sledge apparatus, consisting of squat jumps (SJ), countermovement jumps (CMJ), and drop jumps (DJ).
The inclination of the sledge is 20° to horizontal.
The seat of the sledge is inclined backwards (130°).
A force platform is built in perpendicular to the jumping direction.
A speed sensor is attached to the seat of the sledge, which is used to assess the transition point between braking and push-off phases and to calculate jumping height (in cm).
|
Change from baseline in jumping height at 12 weeks
|
|
Jumping height in countermovement jump
Time Frame: Change from baseline in jumping height at 12 weeks
|
Subjects perform a test protocol on a sledge apparatus, consisting of squat jumps (SJ), countermovement jumps (CMJ), and drop jumps (DJ).
The inclination of the sledge is 20° to horizontal.
The seat of the sledge is inclined backwards (130°).
A force platform is built in perpendicular to the jumping direction.
A speed sensor is attached to the seat of the sledge, which is used to assess the transition point between braking and push-off phases and to calculate jumping height (in cm).
|
Change from baseline in jumping height at 12 weeks
|
|
Jumping height in drop jump
Time Frame: Change from baseline in jumping height at 12 weeks
|
Subjects perform a test protocol on a sledge apparatus, consisting of squat jumps (SJ), countermovement jumps (CMJ), and drop jumps (DJ).
The inclination of the sledge is 20° to horizontal.
The seat of the sledge is inclined backwards (130°).
A force platform is built in perpendicular to the jumping direction.
A speed sensor is attached to the seat of the sledge, which is used to assess the transition point between braking and push-off phases and to calculate jumping height (in cm).
|
Change from baseline in jumping height at 12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Leg press one-repetition maximum
Time Frame: Change from baseline in leg press 1-RM at 12 weeks
|
Leg press one-repetition maximum is defined as the maximum weight (in kg) that the subject can push on a leg press device (Signature Series Leg press Life Fitness).
|
Change from baseline in leg press 1-RM at 12 weeks
|
|
Maximal isometric strength
Time Frame: Change from baseline in maximal isometric strength at 12 weeks
|
Maximal strength (Nm) is measured by means of unilateral isometric knee-extensor tests on a Biodex dynamometer.
|
Change from baseline in maximal isometric strength at 12 weeks
|
|
Maximal isokinetic strength
Time Frame: Change from baseline in maximal isokinetic strength at 12 weeks
|
Maximal strength (Nm) is measured by means of unilateral isokinetic knee-extensor tests on a Biodex dynamometer.
|
Change from baseline in maximal isokinetic strength at 12 weeks
|
|
Stair Climbing performance
Time Frame: Change from baseline in Stair Climbing performance at 12 weeks
|
Stair ascent duration (in s), the time needed to ascent a flight of stairs.
|
Change from baseline in Stair Climbing performance at 12 weeks
|
|
Gait speed
Time Frame: Change from baseline in gait speed at 12 weeks
|
The average speed to walk 10m as fast as possible (in m/s).
|
Change from baseline in gait speed at 12 weeks
|
|
5 repetition sit-to-stand test
Time Frame: Change from baseline in sit-to-stand duration at 12 weeks
|
The time needed to perform 5 sit-to-stand transitions (in s).
|
Change from baseline in sit-to-stand duration at 12 weeks
|
|
6 minute walk distance
Time Frame: Change from baseline in 6min walk distance at 12 weeks
|
The walk distance (in m) covered in 6 min.
|
Change from baseline in 6min walk distance at 12 weeks
|
|
Balance
Time Frame: Change from baseline in balance at 12 weeks
|
Overall balance performance is assessed using the total length of the sway path divided by duration of the measurement (mm/s) in a 30s balance test on a balance board.
|
Change from baseline in balance at 12 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- S60983
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise Training
-
Adiyaman UniversityActive, not recruitingHigh-Intensity Interval Training | Exercise Physiology | Exercise Training AdaptationTurkey (Türkiye)
-
Hamza KucukCompletedExercise Training | Exercise PhysiologyTurkey (Türkiye)
-
Universitaire Ziekenhuizen KU LeuvenCompleted
-
Tel Aviv UniversityUniversity of Colorado, DenverActive, not recruitingExercise TrainingIsrael
-
University of Central FloridaCompleted
-
Boston Children's HospitalCompletedExercise TrainingUnited States
-
University of Southern CaliforniaRoyal & Ancient GroupCompleted
-
California State University, San MarcosCompleted
-
Poznan University of Physical EducationCompletedTraining | Exercise Training | Hormone | Inflammation BiomarkersPoland
-
University of British ColumbiaMOSS ROCK PARK FOUNDATIONNot yet recruiting
Clinical Trials on Exercise intervention
-
VA Office of Research and DevelopmentRecruitingMobility Impairment | Asymptomatic Carotid Stenosis (50-69%)United States
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
University of AarhusRecruiting
-
Glasgow Caledonian UniversityUnknown
-
Turku University HospitalUniversity of Turku; University of Helsinki; Academy of Finland; European Foundation... and other collaboratorsUnknownType 2 Diabetes Mellitus | Healthy VolunteersFinland
-
Hacettepe UniversityHacettepe University Scientific Research Projects Coordination UnitNot yet recruitingSubstrate Oxidation | Postprandial Metabolism | Exercise Physiology | Cardiovascular Risk MarkersTurkey (Türkiye)
-
Medipol UniversityCompleted
-
University Medical Center GroningenDutch Kidney Foundation; Innovation Fund of the Dutch Medical Insurance CompaniesCompletedMetabolic Syndrome | Kidney Transplant | Post-transplant Weight GainNetherlands
-
Istanbul UniversityCompletedGlenohumeral ArthritisTurkey
-
Aristotle University Of ThessalonikiCompleted